Jazz Pharmaceuticals plc buy SVB Leerink LLC
Start price
22.04.26
/
50%
€171.20
Target price
22.04.27
€191.59
Performance (%)
31.78%
Price
28.07.26
€225.60
Summary
This prediction is currently active. With a performance of 31.78% the BUY prediction by SVB_Leerink_LLC is a big success. This prediction currently runs until 22.04.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 1.166% | 1.166% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (JAZZ) had its price target raised by Leerink Partners from $215.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for JAZZ provided by MarketBeat